Frequent cases of RAS-mutated down syndrome acute lymphoblastic leukaemia lack JAK2 mutations
Children with Down syndrome (DS) and acute lymphoblastic leukaemia (ALL) have poorer survival and more relapses than non-DS children with ALL, highlighting an urgent need for deeper mechanistic understanding of DS–ALL. Here, using full-exome or cancer genes-targeted sequencing of 42 ALL samples from...
Saved in:
Main Authors: | Nikolaev, Sergey I., Garieri, Marco, Santoni, Federico, Falconnet, Emilie, Ribaux, Pascale, Guipponi, Michel, Murray, Aoife, Groet, Jürgen, Giarin, Emanuela, Basso, Giuseppe, Nizetic, Dean, Antonarakis, Stylianos E. |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/101511 http://hdl.handle.net/10220/24153 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
by: Koschut, David, et al.
Published: (2022) -
JAK2 mutations in Asian patients with essential thrombocythaemia
by: Wong, G.-C., et al.
Published: (2016) -
A novel activating JAK1 mutation in chronic eosinophilic leukemia
by: William Shomali, et al.
Published: (2022) -
Determination of the JAK2 V617F mutation in thrombosis patients
by: Magmuang S.
Published: (2023) -
Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation
by: Suknuntha K.
Published: (2023)